Cigna’s stock price tumbles on news of deal with Express Scripts

Cigna’s stock price dropped March 8 after the company announced a $67 billion deal to acquire pharmacy benefits manager Express Scripts.

Advertisement

Cigna’s stock price was down 11.46 percent at market close March 8. However, the deal sent Express Scripts shares 8.58 percent higher.

Cigna and Express Scripts anticipate the deal will close by the end of 2018.

More articles on payer issues:

2 senators call on HHS Secretary Alex Azar to probe Anthem’s ED rules
Aetna gives $200k toward protest against gun violence
Cigna opens Middle East headquarters

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.